[TABLE OF CONTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financial data 4 B. Capitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors 7 ITEM 4. INFORMATION ON THE COMPANY 36] [Guangzhou City Real Estate Property Purchase Agreement Seller (Party A): Guangzhou Hezhong CD Manufacturing Co., Ltd. Legal Representative: ZHU Suifeng Buyer (Party B): Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. Legal Representative: ZHENG Ting Article I Party A desires to transfer the real estate property it owns, including the land use right to the surrounding public green area and road] [Hundsun (Hangzhou) Science & Technology Park Property Transfer Agreement Contract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Co., Ltd. Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Co., Ltd. Legal Representative: DENG Yue Article I Background of the Construction Project Party A entered into an agreement “State Construction Land Use Right Transfer Contract” (contract] [List of Subsidiaries Name Jurisdiction China Cord Blood Services Corporation Cayman Islands China Stem Cells Holdings Limited Cayman Islands Beijing Jiachenhong Biological Technologies Co., Ltd. People’s Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. People’s Republic of China Zhejiang Lukou Biotechnology Co., Ltd. People’s Republic of China China Stem Cells (East) Company Limited British Virgin Islands China Stem] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification I, Albert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of China Cord Blood Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [Certification CHINA CORD BLOOD CORPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013 Albert Chen Chief Financial Officer (Principal Financial and Accounting Officer)] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors China Cord Blood Corporation: Hong Kong, China July 31, 2013]

[TABLE OFNTENTS PART I 4 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 4 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 4 ITEM 3. KEY INFORMATION 4 A. Selected financialta 4 B.pitalization and Indebtedness 6 C. Reasons for the Offer and Use of Proceeds 7 D. Risk factors] [Guangzhou City Real Estate Property Purchasereement Seller (Party A):Guangzhou Hezhong CD Manufacturing Legal Representative:ZHU Suifeng Buyer (Party B):Guangzhou Municipality Tianhe Nuoya Bio-engineering Legal Representative:ZHENG Ting Article IParty A desires to transfer the real estate property it owns,luding the land use right to the surrounding public green area and road (See Property Layout Plan attached for] [Hundsun (Hangzhou)ience & Technology Park Property Transferreementntract #: H216 ( Party A (Transferor): Hangzhou Hundsun Baichuan Technology Legal Representative: HU Weiguo Party B (Transferee): Beijing Jiachenhong Biological Technologies Legal Representative: DENG Yue Article IBackground of thenstruction Project Party A entered into anreement Statenstruction Land Use Right Transferntract (contract No. 3301102009A21063) with Hangzhou Municipal Bureau of] [List of Subsidiaries Name Jurisdiction Chinard Blood Servicesrporationyman Islands China Stem Cellss Limitedyman Islands Beijing Jiachenhong Biological Technologies Peoples Republic of China Guangzhou Municipality Tianhe Nuoya Bio-engineering Peoples Republic of China Zhejiang Lukou Biotechnology Peoples Republic of China China Stem Cells (East)mpany Limited] [Certification I, Ting Zheng, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification I,bert Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Chinard Bloodrporation; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification CHINARD BLOODRPORATION July 31, 2013 Ting Zheng Chief Executive Officer July 31, 2013bert Chen Chief Financial Officer (Principal Financial and Accounting Officer) v349858_ex13-1.htm 7 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The Board of Directors Chinard Bloodrporation: Hong Kong, China July 31, 2013 v349858_ex15-1.htm 8 EX-15.1]